Humalog pen (insulin lispro) / Eli Lilly  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Humalog pen (insulin lispro) / Eli Lilly
NCT05373199: A Trial Comparing the Pharmacodynamics and Pharmacokinetics of BC Combo THDB0207 and Lantus® and Humalog® in Subjects With Type 1 Diabetes

Completed
1
30
Europe
Euglycemic clamp with BC Combo THDB0207, Euglycemic clamp with Lantus®, Euglycemic clamp with Humalog®
Adocia, Tonghua Dongbao Pharmaceutical Co.,Ltd
Type 1 Diabetes
10/22
10/22
NCT05262387: A Study of LY900014 (Lyumjev) Versus Insulin Lispro (Humalog) in Participants With Type 1 Diabetes

Completed
1
25
Canada
Lyumjev with 50% basal rate reduction, LY900014, Humalog with 50% basal rate reduction, Insulin Lispro, Humalog with 100% basal rate reduction, Lyumjev with 100% basal rate reduction
Eli Lilly and Company
Diabetes Mellitus, Type 1
03/23
03/23

Download Options